Cleveland, OHNCT06311708Now EnrollingIRB Ready

Arrhythmogenic Right Ventricular Cardiomyopathy Clinical Trial in Cleveland, OH

Access cutting-edge arrhythmogenic right ventricular cardiomyopathy treatment through this clinical trial at a research site in Cleveland. Study-provided care at no cost to qualified participants.

Sponsored by Tenaya Therapeutics

Quick Self-Assessment

See if you qualify for this Cleveland location

Preparing your pre-screening questions…

Expert Care in Cleveland

Access arrhythmogenic right ventricular cardiomyopathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related arrhythmogenic right ventricular cardiomyopathy treatment provided free

Apply for This Cleveland Location

Check if you qualify for this arrhythmogenic right ventricular cardiomyopathy clinical trial in Cleveland, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cleveland

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cleveland site if eligible
  4. 4Begin participation

About This Arrhythmogenic Right Ventricular Cardiomyopathy Study in Cleveland

This is a multicenter, non-interventional study to observe the natural progression of the disease and to study the prevalence of pre-existing antibodies to AAV9 used for gene therapy in a population of patients with PKP2 gene-associated ARVC. Participation from all patients is encouraged regardless of interest in or eligibility for gene therapy.

Sponsor: Tenaya Therapeutics

Who Can Participate

Inclusion Criteria

Ages 14-65 years, inclusive, at the time of consent
Pathogenic or likely pathogenic PKP2 gene mutation
Diagnosed with ARVC and meet 2010 Modified Task Force Criteria for ARVC as affected.
Functioning ICD

Exclusion Criteria

Currently receiving systemic immunosuppressive therapy, cytotoxic chemotherapy, immunoglobulin therapy or monoclonal antibody therapy
History of clinically significant liver disease, hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or tuberculosis infection
Previously dosed with any investigational or approved gene therapy product at any time
Concurrent participation in another interventional clinical trial unless approved by the Sponsor. Participation in a noninterventional study may be allowed at the investigator's discretion.
History of cardiac transplant.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cleveland?

Yes, this clinical trial (NCT06311708) has an active research site in Cleveland, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Arrhythmogenic Right Ventricular Cardiomyopathy Treatment Options in Cleveland, OH

If you're searching for arrhythmogenic right ventricular cardiomyopathy treatment options in Cleveland, OH, this clinical trial (NCT06311708) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cleveland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced arrhythmogenic right ventricular cardiomyopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all arrhythmogenic right ventricular cardiomyopathy clinical trials near you to find additional studies recruiting in your area.

More Cardiomyopathy Trials in Cleveland, OH

See all cardiomyopathy clinical trials recruiting in Cleveland — not just this study.

Browse Cardiomyopathy Trials in Cleveland

Ready to Join in Cleveland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cleveland, OH